Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

You searched for +publisher:"University of Illinois – Chicago" +contributor:("Smith Marsh, Daphne E"). One record found.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of Illinois – Chicago

1. Adimadhyam, Sruthi. Comparative Safety of Sodium-Glucose Co-Transporter 2 Inhibitors.

Degree: 2018, University of Illinois – Chicago

More than 30 million people living in the US have diabetes. Over time, increased concentrations of glucose in the blood lead to cellular damage and cause a variety of serious complications in these individuals. Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) are the latest class of oral antidiabetic medications approved for use in the US. They work by blocking the resorption of glucose in the kidney thereby increasing urinary glucose excretion. Due to their distinct mechanism of action, these drugs demonstrate cardio- and reno-protective effects in addition to their antihyperglycemic effect. However, clinical trials report an increased risk for adverse events such as amputations, fractures, and mycotic infections raising concerns about their safety. The objective of this dissertation was to evaluate the comparative safety of these drugs in a real-world setting outside of clinical trials. Three observational studies were conducted using prescription and medical insurance data from Truven Health MarketScan Databases (2009-2015). The first study investigated the association between SGLT2i and amputations and concluded that the potential for harm cannot be ruled out. While there was a 38% increase in risk for amputations following initiation of treatment with SGLT2i, the 95% confidence interval included the null. The second study investigated the association between SGLT2i and fractures. There was an 82% increase in risk for fractures early in treatment with SGLT2i. Beyond the initial 2-week treatment period, there was no apparent effect on fracture risk. The third study investigated the association between SGLT2i and mycotic infections. There was a 53% increase in risk for mycotic infections within the first 90 days of treatment with SGLT2i. This dissertation evaluated the post-marketing safety of this new class of antidiabetic medications in a real-world setting. Evidence from such observational studies can supplement that from clinical trials to more thoroughly inform decision-making. Findings from this research can help clinicians understand patients at high-risk for experiencing these events and devise remedial measures in anticipation. Advisors/Committee Members: Schumock, Glen T (advisor), Lee, Todd A (committee member), Calip, Gregory S (committee member), Smith Marsh, Daphne E (committee member), Layden, Brian T (committee member), Schumock, Glen T (chair).

Subjects/Keywords: pharmacoepidemiology; drug safety; SGLT2 inhibitors; type 2 diabetes; amputations; fractures; mycotic infections

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Adimadhyam, S. (2018). Comparative Safety of Sodium-Glucose Co-Transporter 2 Inhibitors. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/23328

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Adimadhyam, Sruthi. “Comparative Safety of Sodium-Glucose Co-Transporter 2 Inhibitors.” 2018. Thesis, University of Illinois – Chicago. Accessed March 05, 2021. http://hdl.handle.net/10027/23328.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Adimadhyam, Sruthi. “Comparative Safety of Sodium-Glucose Co-Transporter 2 Inhibitors.” 2018. Web. 05 Mar 2021.

Vancouver:

Adimadhyam S. Comparative Safety of Sodium-Glucose Co-Transporter 2 Inhibitors. [Internet] [Thesis]. University of Illinois – Chicago; 2018. [cited 2021 Mar 05]. Available from: http://hdl.handle.net/10027/23328.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Adimadhyam S. Comparative Safety of Sodium-Glucose Co-Transporter 2 Inhibitors. [Thesis]. University of Illinois – Chicago; 2018. Available from: http://hdl.handle.net/10027/23328

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

.